Today: 27 January 2026
Subscribe
Browse Category

NASDAQ:LGND News 13 January 2026

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

Ligand Pharmaceuticals stock slides as FDA pushes back Travere’s Filspari decision to April 13

NEW YORK, Jan 13, 2026, 14:32 (EST) — Regular session Shares of Ligand Pharmaceuticals Incorporated dropped 10.6% to $184.80 in Tuesday afternoon trading. The decline followed an announcement from royalty partner Travere Therapeutics that U.S. regulators extended the review period for its Filspari application, pushing the decision date to April 13. Travere said the FDA classified its latest submission as…
13 January 2026
·····

Stock Market Today

  • Soybeans Retreat from Early Gains as Export Data Shows Mixed Signals
    January 27, 2026, 1:25 AM EST. Soybean futures dropped 4 to 5 cents on Monday after initial overnight gains, with March contracts at $10.63 per bushel. The national average cash soybean price rose slightly to $9.93 1/4. Export inspections revealed shipments of 1.324 million metric tons last week, down 1.54% from the week before but up nearly 80% year-on-year. China remained the largest destination. Marketing year shipments have increased 37.5% year-on-year. However, recent export sales are 22% below last year, underperforming USDA projections. Speculative traders reduced net long positions by nearly 3,000 contracts, reflecting cautious sentiment. Brazil's harvest is progressing briskly with a crop estimate raised to 181 million metric tons. Soymeal futures fell $3.90 to $4.70, while soy oil futures inched higher, indicating mixed demand pressures across related commodities.
Go toTop